Frontiers in Immunology (Jun 2023)
Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
- A. D. Meringa,
- P. Hernández-López,
- A. Cleven,
- M. de Witte,
- M. de Witte,
- T. Straetemans,
- T. Straetemans,
- J. Kuball,
- J. Kuball,
- D. X. Beringer,
- Z. Sebestyen
Affiliations
- A. D. Meringa
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- P. Hernández-López
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- A. Cleven
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- M. de Witte
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- M. de Witte
- Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- T. Straetemans
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- T. Straetemans
- Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- J. Kuball
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- J. Kuball
- Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- D. X. Beringer
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- Z. Sebestyen
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- DOI
- https://doi.org/10.3389/fimmu.2023.1159337
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
